[1] Zhou J, Austin RC. Contributions of hyperhomocysteinemia to atherosclerosis:causal relationship and potential mechanisms[J]. Biofactors, 2009, 35(2):120-129. [2] Lakshmi SV, Padmaja G, Kuppusamy P, et al. Oxidative stress in cardiovascular disease[J]. Indian J Biochem Biophys, 2009, 46(6):421-440. [3] Tascilar N, Ekem S, Aciman E, et al. Hyperhomocysteinemia as an independent risk factor for cardioembolic stroke in the Turkish population[J]. Tohoku J Exp Med, 2009, 218(4):293-300. [4] Atamer A, Bilici A, Yenice N, et al. The importance of paraoxonase 1 activity, nitric oxide and lipid per-oxidation in hepatosteatosis[J]. J Int Med Res, 2008, 36(4):771-776. [5] Antoniades C, Antonopoulos AS, Tousoulis D, et al. Homocysteine and coronary atherosclerosis:from folate fortification to the recent clinical trials[J]. European Heart J, 2009, 30(1):6-15. [6] 陈晓蓓, 徐根云, 吕国才. 冠心病血清对氧磷酯酶1活性与氧化功能指标的研究[J].检验医学, 2007, 22(4):488-489. [7] Ferretti G, Bacchetti T, Masciangelo S, et al. Effect of homocysteinylation on high density lipoprotein physico-chemical properties[J]. Chem Phys Lipids, 2010, 163(2):228-235. [8] Atamer A, Kocyigit Y, Ecder SA, et al. Effect of oxidative stress on antioxidant enzyme activities, homocysteine and lipoproteins in chronic kidney disease[J]. J Nephrol, 2008, 21(6):924-930. [9] Antoniades C, Shirodaria C, Warrick N, et al. 5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels:effects on vascular tetrahydrobiopterinavailability and endothelial nitric oxide synthase coupling[J]. Circulation, 2006, 114(11):1193-1201. [10] Hoffman M. Hypothesis:hyperhomocysteinemia is an indicator of oxidant stress[J]. Med Hypotheses, 2011, 77(6):1088-1093. [11] Sharma M, Rai SK, Tiwari RK, et al. Effects of nitric oxide modulators on cardiovascular risk factors in mild hyperhomocysteinaemic rat model[J]. Basic Clin Pharmacol Toxicol, 2008, 103(1):25-30. [12] Veresh Z, Racz A, Lotz G, et al. ADMA impairs nitric oxide-mediated arteriolar function due to increased superoxide production by angiotensin Ⅱ-NAD(P)H oxidase pathway[J]. Hypertension, 2008, 52(5):960-966. |